Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation. (Q51791167)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

head and neck squamous cell carcinoma

22 January 2020

main subject

chemoradiotherapy

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Leendert Looijenga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Guido B van den Broek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Maarten Wildeman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Coen R N Rasch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ed Schuuring

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Adrian C Begg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Rik Scheper

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jacqueline E van der Wal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lorian Menkema

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Paul J van Diest

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Alfons J M Balm

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Marie-Louise F van Velthuysen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michiel W M van den Brekel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

English

0 references

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

2643-2650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253368%20AND%20SRC:MED&resulttype=core&format=json

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

22 January 2020

cites work

1 reference

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

21 January 2018

1 reference

Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma

21 January 2018

1 reference

Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy

21 January 2018

1 reference

Genetic imbalances with impact on survival in head and neck cancer patients

21 January 2018

1 reference

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

21 January 2018

1 reference

Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy

21 January 2018

1 reference

The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy

21 January 2018

1 reference

P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy

21 January 2018

1 reference

Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma

21 January 2018

1 reference

Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.

21 January 2018

1 reference

Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation

21 January 2018

1 reference

Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas

21 January 2018

1 reference

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

Tissue microarrays (TMAs) for high-throughput molecular pathology research.

21 January 2018

1 reference

Validation of tissue array technology in head and neck squamous cell carcinoma

21 January 2018

1 reference

High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer

21 January 2018

1 reference

Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.

21 January 2018

1 reference

Bcl-2 expression predicts radiotherapy failure in laryngeal cancer

21 January 2018

1 reference

Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.

21 January 2018

1 reference

Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?

21 January 2018

1 reference

HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors

21 January 2018

1 reference

A global test for groups of genes: testing association with a clinical outcome

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma

21 January 2018

1 reference

Molecular markers in clinical radiation oncology

21 January 2018

1 reference

MRP2 and 3 in health and disease

21 January 2018

1 reference

The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance

21 January 2018

1 reference

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells

21 January 2018

1 reference

MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma

21 January 2018

1 reference

The apical conjugate efflux pump ABCC2 (MRP2).

21 January 2018

1 reference

Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.

21 January 2018

1 reference

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

21 January 2018

1 reference

Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts

21 January 2018

1 reference

Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence

21 January 2018

1 reference

Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.

21 January 2018

1 reference

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number

21 January 2018

1 reference

Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

21 January 2018

1 reference